Banner

Treating glaucoma is not just black and white

Article

Editor's Note: This is the final story in a three-part series covering a forum on "Ethnicity and Glaucoma" at Johns Hopkins University to commemorate the 20th anniversary of the Baltimore Eye Survey.

Related Videos
Promising results for faricimab revealed in TENAYA, LUCERNE year 2 data
Orbis in-person training takes flight once again
Elkin: Talking about the importance of pediatric eye health and safety
Eye stroke: Mount Sinai program stresses awareness and emergent care for sudden vision loss
Related Content

Macular leakage is important in diabetic eye disease outcomes

September 21st 2023

(Podcast) Confronting Demodex blepharitis: From rude awakening to FDA-approved solution

August 30th 2023

Pearls for management of Pseudomonas scleritis

July 19th 2023

EyePod: The dry eye pipeline is more than a topical discussion

June 29th 2023

MRI findings show inebilizumab-cdon reduced formation of spinal cord lesions in patients diagnosed with neuromyelitis optica spectrum disorder

July 2nd 2023

Understanding options for combination myopia management

May 29th 2023

Macular leakage is important in diabetic eye disease outcomes

September 21st 2023

(Podcast) Confronting Demodex blepharitis: From rude awakening to FDA-approved solution

August 30th 2023

Pearls for management of Pseudomonas scleritis

July 19th 2023

EyePod: The dry eye pipeline is more than a topical discussion

June 29th 2023

MRI findings show inebilizumab-cdon reduced formation of spinal cord lesions in patients diagnosed with neuromyelitis optica spectrum disorder

July 2nd 2023

Understanding options for combination myopia management

May 29th 2023

Macular leakage is important in diabetic eye disease outcomes

September 21st 2023

(Podcast) Confronting Demodex blepharitis: From rude awakening to FDA-approved solution

August 30th 2023

Pearls for management of Pseudomonas scleritis

July 19th 2023

EyePod: The dry eye pipeline is more than a topical discussion

June 29th 2023

MRI findings show inebilizumab-cdon reduced formation of spinal cord lesions in patients diagnosed with neuromyelitis optica spectrum disorder

July 2nd 2023

Understanding options for combination myopia management

May 29th 2023
© 2023 MJH Life Sciences

All rights reserved.